Publicacións en colaboración con investigadores/as de McGill University (15)

2024

  1. Agreement between local and central anti-synthetase antibodies detection: results from the Classification Criteria of Anti-Synthetase Syndrome project biobank

    Clinical and experimental rheumatology, Vol. 42, Núm. 2, pp. 277-287

  2. Modulation of Abundance and Location of High-Mobility Group Box 1 in Human Microglia and Macrophages under Oxygen-Glucose Deprivation

    ACS Pharmacology and Translational Science, Vol. 7, Núm. 3, pp. 680-692

  3. Thrombolytic therapy based on lyophilized platelet-derived nanocarriers for ischemic stroke

    Journal of Nanobiotechnology, Vol. 22, Núm. 1

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative

    PLoS genetics, Vol. 18, Núm. 11, pp. e1010367

  2. Identifying the research, advocacy, policy and implementation needs for the prevention and management of respiratory syncytial virus lower respiratory tract infection in low- and middle-income countries

    Frontiers in Pediatrics, Vol. 10

  3. Mapping genomic loci implicates genes and synaptic biology in schizophrenia

    Nature, Vol. 604, Núm. 7906, pp. 502-508

  4. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  5. Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)

    Nature

  6. Sex-biased expression of the TLR7 gene in severe COVID-19 patients: Insights from transcriptomics and epigenomics

    Environmental Research, Vol. 215

  7. Stroke genetics informs drug discovery and risk prediction across ancestries

    Nature, Vol. 611, Núm. 7934, pp. 115-123

2021

  1. New approaches in nanomedicine for ischemic stroke

    Pharmaceutics, Vol. 13, Núm. 5

2017

  1. Early Mortality in a Multinational Systemic Sclerosis Inception Cohort

    Arthritis and Rheumatology, Vol. 69, Núm. 5, pp. 1067-1077

2013

  1. Identification of three new cis-regulatory IRF5 polymorphisms: In vitro studies

    Arthritis Research and Therapy, Vol. 15, Núm. 4

2011

  1. Cis-regulation of IRF5 expression is unable to fully account for systemic lupus erythematosus association: Analysis of multiple experiments with lymphoblastoid cell lines

    Arthritis Research and Therapy, Vol. 13, Núm. 3